Fluidigm Corporation (FLDM): Price and Financial Metrics


Fluidigm Corporation (FLDM)

Today's Latest Price: $6.12 USD

0.37 (6.43%)

Updated Nov 27 1:00pm

Add FLDM to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

FLDM Stock Summary

  • With a year-over-year growth in debt of 68.37%, Fluidigm Corp's debt growth rate surpasses 85.24% of about US stocks.
  • In terms of volatility of its share price, FLDM is more volatile than 90.82% of stocks we're observing.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for FLDM comes in at -5.88% -- higher than that of 30.65% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Fluidigm Corp, a group of peers worth examining would be MBII, CTSO, ICAD, URG, and OBLN.
  • FLDM's SEC filings can be seen here. And to visit Fluidigm Corp's official web site, go to www.fluidigm.com.

FLDM Stock Price Chart Interactive Chart >

Price chart for FLDM

FLDM Price/Volume Stats

Current price $6.12 52-week high $12.45
Prev. close $5.75 52-week low $1.17
Day low $5.67 Volume 1,138,258
Day high $6.14 Avg. volume 3,149,146
50-day MA $6.85 Dividend yield N/A
200-day MA $5.12 Market Cap 453.61M

Fluidigm Corporation (FLDM) Company Bio


Fluidigm Corporation develops, manufactures, and markets life science analytical and preparatory systems for growth markets such as single-cell biology and production genomics. The company was founded in 1999 and is based in South San Francisco, California.


FLDM Latest News Stream


Event/Time News Detail
Loading, please wait...

FLDM Latest Social Stream


Loading social stream, please wait...

View Full FLDM Social Stream

Latest FLDM News From Around the Web

Below are the latest news stories about Fluidigm Corp that investors may wish to consider to help them evaluate FLDM as an investment opportunity.

Fluidigm receives additional $22M funding for expansion of Covid testing capacity

On September 28, Fluidigm ([[FLDM]] +3.0%) signs a definite agreement with National Institute of Health for a program aimed at increasing the number, type, and availability of tests for Covid-19.The project funding increased ~$22M, to bring the total contract value at $34M.This will help expand production capacity and throughput capabilities...

Seeking Alpha | September 29, 2020

INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Fluidigm Corporation

NEW YORK--(BUSINESS WIRE)---- $FLDM #classaction--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Fluidigm Corporation (“Fluidigm” or the “Company”) (NASDAQ: FLDM) securities during the period from February 7, 2019 through November 5, 2019, inclusive (the “Class Period”). Investors have until November 23, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit

Business Wire | September 24, 2020

FLDM Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fluidigm Corporation Investors of Class Action and Encourages Shareholders to Contact the Firm

NEW YORK, Sept. 23, 2020 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fluidigm Corporation ("Fluidigm" or "the Company") (NASDAQ: FLDM) and certain of its officers, on behalf of…

PR Newswire | September 23, 2020

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Fluidigm Corporation (FLDM) Investors

LOS ANGELES--(BUSINESS WIRE)---- $FLDM #classaction--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Fluidigm Corporation (“Fluidigm” or the “Company”) (NASDAQ: FLDM) securities between February 7, 2019 and November 5, 2019, inclusive (the “Class Period”). Fluidigm investors have until November 20, 2020 to file a lead plaintiff motion. If you are a shareholder who suffered a loss, click here to participate. On

Business Wire | September 22, 2020

FLDM CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Fluidigm Corporation

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California captioned Saintjermain v. Fluidigm Corporation, et al., (Case No. 20-cv-06617) on behalf of persons and entities that purchased or otherwise acquired Fluidigm Corporation (“Fluidigm” or the “Company”) (NASDAQ: FLDM) securities between February 7, 2019 and November 5, 2019, inclusive (the “Class Period

Business Wire | September 21, 2020

Read More 'FLDM' Stories Here

FLDM Price Returns

1-mo 2.86%
3-mo -27.57%
6-mo 40.37%
1-year 144.80%
3-year 6.07%
5-year -42.26%
YTD 75.86%
2019 -59.63%
2018 46.35%
2017 -19.09%
2016 -32.65%
2015 -67.95%

Continue Researching FLDM

Want to see what other sources are saying about Fluidigm Corp's financials and stock price? Try the links below:

Fluidigm Corp (FLDM) Stock Price | Nasdaq
Fluidigm Corp (FLDM) Stock Quote, History and News - Yahoo Finance
Fluidigm Corp (FLDM) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9201 seconds.